Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.
van Geel
Peter Paul
PP
Department of Clinical Pharmacology and Cardiology, University Hospital, Groningen, The Netherlands.
Buikema
Hendrik
H
Rouleau
Jean-Lucien
JL
van Gilst
Wiek H
WH
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D017558:Elective Surgical Procedures; D005260:Female; D005838:Genotype; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000097:blood* / Q000235:genetics*; D000077583:Quinapril; D044005:Tetrahydroisoquinolines
D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D007703:Peptidyl-Dipeptidase A; D000077583:Quinapril